Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Trojani, G. Contesso, J. Coindre, J. Rouesse, N. Bui, A. Mascarel, J. Goussot, M. David, F. Bonichon, C. Lagarde (1984)
Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading systemInternational Journal of Cancer, 33
BD Smith, GL Smith, A Hurria, GN Hortobagyi, TA Buchholz (2009)
Future of cancer incidence in the United States: burdens upon an aging, changing nationJ Clin Oncol, 27
M. Okamoto, M. Kito, Y. Yoshimura, Kaoru Aoki, Shuichiro Suzuki, Atsushi Tanaka, A. Takazawa, Kazushige Yoshida, Hiroyuki Kato (2018)
The status quo of treatment and clinical outcomes for patients over 80 years of age with high-grade soft tissue sarcoma: report from the soft tissue tumor registry in JapanJapanese Journal of Clinical Oncology, 48
Jean-Yves Blay, P. Soibinet, Nicolas Penel, E. Bompas, F. Duffaud, E. Stoeckle, O. Mir, J. Adam, C. Chevreau, S. Bonvalot, M. Ríos, P. Kerbrat, D. Cupissol, P. Anract, F. Gouin, J. Kurtz, C. Lebbé, N. Isambert, F. Bertucci, M. Toumonde, A. Thyss, S. Piperno-Neumann, P. Dubray-Longeras, P. Meeus, F. Ducimetière, A. Giraud, J. Coindre, I. Ray-Coquard, A. Italiano, A. Cesne (2017)
Improved survival using specialized multidisciplinary board in sarcoma patientsAnnals of Oncology, 28
J. Hui (2016)
Epidemiology and Etiology of Sarcomas.The Surgical clinics of North America, 96 5
M Okamoto, M Kito, Y Yoshimura, K Aoki, S Suzuki, A Tanaka (2018)
The status quo of treatment and clinical outcomes for patients over 80 years of age with high-grade soft tissue sarcoma: report from the soft tissue tumor registry in JapanJpn J Clin Oncol, 48
BP Rubin, CR Antonescu, FH Gannon, JL Hunt, CY Inwards, MJ Klein (2010)
Members of the Cancer Committee College of American Pathologists Protocol for the examination of specimens from patients with tumors of boneArch Pathol Lab Med, 134
B. Rubin, C. Antonescu, F. Gannon, J. Hunt, C. Inwards, M. Klein, J. Kneisl, A. Montag, T. Peabody, J. Reith, A. Rosenberg, T. Krausz (2010)
Protocol for the examination of specimens from patients with tumors of bone.Archives of pathology & laboratory medicine, 134 4
M. Hoven-Gondrie, E. Bastiaannet, V. Ho, B. Leeuwen, G. Liefers, H. Hoekstra, A. Suurmeijer (2016)
Worse Survival in Elderly Patients with Extremity Soft-Tissue SarcomaAnnals of Surgical Oncology, 23
Zachary Burningham, M. Hashibe, L. Spector, J. Schiffman (2012)
The Epidemiology of SarcomaClinical Sarcoma Research, 2
Alicia Gingrich, S. Bateni, A. Monjazeb, S. Thorpe, A. Kirane, R. Bold, R. Canter (2019)
Extremity soft tissue sarcoma in the elderly: Are we overtreating or undertreating this potentially vulnerable patient population?Journal of Surgical Oncology, 119
W. Al-Refaie, E. Habermann, V. Dudeja, S. Vickers, T. Tuttle, E. Jensen, B. Virnig (2010)
Extremity Soft Tissue Sarcoma Care in the Elderly: Insights into the Generalizability of NCI Cancer TrialsAnnals of Surgical Oncology, 17
R. Siegel, K. Miller, Hannah Fuchs, A. Jemal (2022)
Cancer statistics, 2022CA: A Cancer Journal for Clinicians, 72
S Schroyen, S Adam, G Jerusalem, P Missotten (2014)
Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leadsClin Interv Aging, 31
Lawrence Schwartz, Lawrence Schwartz, L. Seymour, S. Litière, R. Ford, S. Gwyther, S. Mandrekar, L. Shankar, J. Bogaerts, A. Chen, J. Dancey, W. Hayes, F. Hodi, O. Hoekstra, Erich Huang, Nan Lin, Yan Liu, P. Therasse, J. Wolchok, J. Wolchok, J. Wolchok, E. Vries (2016)
RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group.European journal of cancer, 62
The number of elderly patients diagnosed with cancer is increasing. However, knowledge regarding cancer in elderly patients is very scarce. The aim of this study is to analyze the differences in management and outcomes of high-grade extremity sarcomas between elderly and middle-aged patients.Two cohorts were made (> 70 and 30/50 years old) among patients treated in a multidisciplinary unit of a national reference center between 2011 and 2017 with a minimum of 2 years of follow-up. The management and outcomes between these two cohorts were compared.Seventy patients were included, 34 young patients and 36 elderly patients. The only difference between the treatment schemes was the chemotherapy used, 67.6% of the young patients received chemotherapy versus 16.7% of the elderly patients (p = 0.000015). There were no differences either in the overall survival or the progression-free survival between groups at 1 and 2-year follow-up. Deceases for other causes were nearly exclusive of elderly patients at a median of 45.57 months.Surgery is the treatment of choice for sarcomas in both elderly and young patients having similar results in terms of progression-free survival, overall survival, and surgery outcomes. The use of chemotherapy is the only difference in the treatment schemes between both groups. In the elderly patient with minimal or no comorbidity and good functional reserve, surgical curative treatment should be chosen. As for frail elderly patients, the therapeutic objectives must be focused mainly on quality of life and palliation of symptoms.
Indian Journal of Surgical Oncology – Springer Journals
Published: Sep 27, 2022
Keywords: Sarcoma; Surgery; Surgical resection; Elderly
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.